Myeloperoxidase Luminol Reaction – A Novel Faecal Assay for Predicting Colonoscopy Findings in Patients with Ulcerative Colitis: A Pilot Cross‐Sectional Clinical Study
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202501825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Viraj Kariyawasam und 14 weiteren Autor:innen. Beteiligte Einrichtung: Blacktown/Mt. Druitt Clinical School, University of Western Sydney, Sydney, NSW, 2148, Australia. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colonoscopy, Peroxidase, Feces. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Faculty of Medicine and Health, University of Sydney, Crohn's and Colitis Foundation.
Abstract (Originalsprache)
Inflammatory Bowel Disease (IBD), including ulcerative colitis (UC), requires non‐invasive, convenient and cost‐effective biomarkers for disease monitoring. Myeloperoxidase (MPO), a neutrophil‐derived enzyme, correlates with intestinal inflammation. This study aims to assess the Myeloperoxidase Luminol Reaction (MPOLR) assay – a novel chemiluminescent‐based method for detecting faecal MPO (fMPO) activity, to improve the prediction of endoscopic findings in UC. A cross‐sectional clinical study recruited 39 participants, categorized into UC (n = 20), colonoscopy control (CC; n = 9), and healthy control (HC; n = 10). Faecal samples are analysed for fMPO, calprotectin (fCalpro), and lactoferrin (fLacto) using ELISA and the MPOLR assay. The MPOLR assay is validated against endoscopic disease severity (UCEIS), symptomology, and clinical indices. MPOLR strongly correlated with UCEIS (ρ = 0.78), disease severity (ρ = 0.75), and symptomology (ρ = 0.78), outperforming fCalpro (ρ = 0.58, ρ = 0.57, and ρ = 0.41, respectively). AUROC analysis reveals MPOLR (0.78) and fMPO (0.75) have superior predictive potential for UC diagnosis compared to fCalpro (0.66). MPOLR is a rapid, cost‐effective assay that enhances UC monitoring by accurately reflecting endoscopic findings and outcompetes fCalpro and other faecal biomarkers’ predictive potential for UC diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blacktown/Mt. Druitt Clinical School, University of Western Sydney, Sydney, NSW, 2148, Australia.
- Department of Gastroenterology, Concord Repatriation General hospital, Sydney, NSW, 2139, Australia.
- Redox Inflammation Group, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, 2006, Australia.
- Biomedical Engineering, Faculty of Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.
- The Westmead Institute for Medical Research, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Westmead, Sydney, NSW, 2145, Australia.
- School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, 4222, Australia.
ORCID-Profile: Belal Chami
Förderung
- Faculty of Medicine and Health, University of Sydney
- Crohn's and Colitis Foundation
Zitieren
APA
Kariyawasam, V., Davis, T., Ghali, M., Tejcek, D., R O'Neil, T., Verley, E., Griffiths, M., Campos, M., Bonney, I., Bulmer, A. C., Ramaswamy, Y., Mitrev, N., Corte, C., Witting, P. K., & Chami, B. (2026). Myeloperoxidase Luminol Reaction – A Novel Faecal Assay for Predicting Colonoscopy Findings in Patients with Ulcerative Colitis: A Pilot Cross‐Sectional Clinical Study. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501825
Vancouver
Kariyawasam V, Davis T, Ghali M, Tejcek D, R O'Neil T, Verley E, et al. Myeloperoxidase Luminol Reaction – A Novel Faecal Assay for Predicting Colonoscopy Findings in Patients with Ulcerative Colitis: A Pilot Cross‐Sectional Clinical Study. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501825
BibTeX
@article{Kariyawasam2026,
author = {Kariyawasam, Viraj and Davis, Taylor and Ghali, Mark and Tejcek, David and R O'Neil, Thomas and Verley, Ella and Griffiths, Matthew and Campos, Miguel and Bonney, Ingrid and Bulmer, Andrew C and Ramaswamy, Yogambha and Mitrev, Nikola and Corte, Crispin and Witting, Paul K and Chami, Belal},
title = {Myeloperoxidase Luminol Reaction – A Novel Faecal Assay for Predicting Colonoscopy Findings in Patients with Ulcerative Colitis: A Pilot Cross‐Sectional Clinical Study},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202501825}
}
EUVIMED